Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice
- 6 December 2002
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 64A (1), 177-181
- https://doi.org/10.1002/jbm.a.10396
Abstract
Basic fibroblast growth factor (bFGF) has been shown to stimulate wound healing. However, consistent delivery of bFGF has been problematic. We studied the stability of bFGF incorporated into a chitosan film as a delivery vehicle for providing sustained release of bFGF. The therapeutic effect of this system on wound healing in genetically diabetic mice was determined as a model for treating clinically impaired wound healing. A chitosan film was prepared by freeze-drying hydroxypropylchitosan (a water-soluble derivative of chitosan) acetate buffer solution. Growth factor was incorporated into films before drying by mixing bFGF solution with the hydroxypropylchitosan solution. bFGF activity remained stable for 21 days at 5°C, and 86.2% of activity remained with storage at 25°C. Full-thickness wounds were created on the backs of diabetic mice, and chitosan film or bFGF-chitosan film was applied to the wound. The wound was smaller in after 5 days in both groups, but the wound was smaller on day 20 only in the bFGF-chitosan group. Proliferation of fibroblasts and an increase in the number of capillaries were observed in both groups, but granulation tissue was more abundant in the bFGF-chitosan group. These results suggest that chitosan itself facilitates wound repair and that bFGF incorporated into chitosan film is a stabile delivery vehicle for accelerating wound healing. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 64A:177–181, 2003Keywords
This publication has 17 references indexed in Scilit:
- Acceleration of Wound Healing in Diabetic Mice by Basic Fibroblast Growth Factor.Biological & Pharmaceutical Bulletin, 1996
- Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetateJournal of Biomedical Materials Research, 1995
- Effect of Topical Basic Fibroblast Growth Factor on the Healing of Chronic Diabetic Neuropathic Ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled studyDiabetes Care, 1995
- Basic Fibroblast Growth Factor Has a Beneficial Effect on the Viability of Random Skin Flaps in RatsAnnals of Plastic Surgery, 1994
- Aluminium β-Cyclodextrin Sulphate as a Stabilizer and Sustained-release Carrier for Basic Fibroblast Growth FactorJournal of Pharmacy and Pharmacology, 1994
- The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure SoresAnnals of Surgery, 1992
- Basic Fibroblast Growth Factor Stimulation of Epidermal Wound Healing in PigsJournal of Investigative Dermatology, 1990
- Structural Characterization and Biological Functions of Fibroblast Growth FactorEndocrine Reviews, 1987
- Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cellsCell Differentiation, 1986
- Sustained release of indomethacin from chitosan granules.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985